Health-related quality of life in patients with unresectable hepatocellular carcinoma treated with SIRT and nivolumab: a sub-analysis of the NASIR-HCC trial

Health-related quality of life in patients with unresectable hepatocellular carcinoma treated with SIRT and nivolumab: a sub-analysis of the NASIR-HCC trial

Abstract Background The health-related quality of life (HRQoL) impact of therapies for hepatocellular carcinoma (HCC) influences decision-making and treatment outcomes. The present study reports HRQoL results from NASIR-HCC, a single-arm study of selective internal radiation therapy (SIRT) with Y90...

Full description

Saved in:
Bibliographic Details
Main Authors: Manuel De la Torre-Aláez, Ana Matilla, María Varela, Mercedes Iñarrairaegui, María Reig, José Luis Lledó, Juan Ignacio Arenas, Sara Lorente, Milagros Testillano, Laura Márquez, Gemma Iserte, Josepmaria Argemí, Carlos Gómez-Martin, Macarena Rodríguez-Fraile, José I. Bilbao, Richard F. Pollock, Johannes Pöhlmann, Ion Agirrezabal, Bruno Sangro
Format: Article
Language:English
Published: SpringerOpen 2025-04-01
Series:Journal of Patient-Reported Outcomes
Subjects:
Hepatocellular carcinoma
Quality of life
Selective internal radiation therapy
SIR-Spheres
Nivolumab
Immunotherapy
Online Access:https://doi.org/10.1186/s41687-025-00873-6
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s41687-025-00873-6

Similar Items